On Tuesday, Terns Pharmaceuticals Inc (NASDAQ: TERN) was 5.17% up from the session before settling in for the closing price of $6.58. A 52-week range for TERN has been $4.32 – $11.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -20.00%. When this article was written, the company’s average yearly earnings per share was at 5.73%. With a float of $62.16 million, this company’s outstanding shares have now reached $84.92 million.
The extent of productivity of a business whose workforce counts for 66 workers is very important to gauge. In terms of profitability, gross margin is 47.35%, operating margin of -7562.78%, and the pretax margin is -6641.75%.
Terns Pharmaceuticals Inc (TERN) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Terns Pharmaceuticals Inc stocks. The insider ownership of Terns Pharmaceuticals Inc is 26.82%, while institutional ownership is 71.51%. The most recent insider transaction that took place on Dec 05 ’24, was worth 110,468. In this transaction Chief Executive Officer of this company bought 15,450 shares at a rate of $7.15, taking the stock ownership to the 19,099 shares. Before that another transaction happened on Sep 12 ’24, when Company’s Director bought 476,190 for $10.50, making the entire transaction worth $4,999,995. This insider now owns 476,190 shares in total.
Terns Pharmaceuticals Inc (TERN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.73% per share during the next fiscal year.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
You can see what Terns Pharmaceuticals Inc (TERN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 32.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
The latest stats from [Terns Pharmaceuticals Inc, TERN] show that its last 5-days average volume of 2.38 million was superior to 1.32 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 54.64%. Additionally, its Average True Range was 0.49.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 24.58%, which indicates a significant decrease from 73.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.18% in the past 14 days, which was lower than the 77.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.95, while its 200-day Moving Average is $7.09. Now, the first resistance to watch is $7.17. This is followed by the second major resistance level at $7.41. The third major resistance level sits at $7.59. If the price goes on to break the first support level at $6.75, it is likely to go to the next support level at $6.57. Assuming the price breaks the second support level, the third support level stands at $6.33.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
There are 84,939K outstanding shares of the company, which has a market capitalization of 587.78 million. As of now, sales total 0 K while income totals -90,210 K. Its latest quarter income was 0 K while its last quarter net income were -21,950 K.
